A detailed history of Marshall & Sterling Wealth Advisors Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Marshall & Sterling Wealth Advisors Inc. holds 184 shares of NVO stock, worth $13,678. This represents 0.01% of its overall portfolio holdings.

Number of Shares
184
Previous 138 33.33%
Holding current value
$13,678
Previous $11.8 Million 8.35%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$69.3 - $90.95 $3,187 - $4,183
46 Added 33.33%
184 $12.8 Million
Q4 2024

Feb 14, 2025

BUY
$85.0 - $120.04 $11,730 - $16,565
138 New
138 $11.8 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $168B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Marshall & Sterling Wealth Advisors Inc. Portfolio

Follow Marshall & Sterling Wealth Advisors Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall & Sterling Wealth Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Marshall & Sterling Wealth Advisors Inc. with notifications on news.